Annexon Biosciences share price logo

Annexon Biosciences

NASDAQ: ANNX

Small Cap

$5.05

-0.02

(-0.30%)

as on

Annexon Biosciences Stock Performance

as on August 25, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $4.80
    $5.13
    downward going graph

    4.95%

    Downside

    1.58%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $2.03
    $7.18
    downward going graph

    59.80%

    Downside

    42.18%

    Upside

    downward going graph

Annexon Biosciences share price movements today

Previous Close
$5.07
Open
$5.03
Volume
3.3M
Market Cap
$866.7M
Day's Low - High
$4.80 - $5.13
52 Week Low - High
$2.03 - $7.18

Annexon Biosciences Historical Returns

1 Month Return
-8.79 %
3 Month Return
+ 1.54 %
1 Year Return
+ 116.8 %
3 Year Return
+ 78.11 %
5 Year Return
-71.41 %

Annexon Biosciences Stock Fundamentals & Key Indicators

Check Annexon Biosciences market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$866.7M

EPS (TTM)

-1.16

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-4.53

Industry PE ratio

-7.283372093023256

PEG Ratio

-0.52266570634154

EBITDA

-199.7M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-106.15%

Annexon Biosciences Stock Valuation

Track how Annexon Biosciences P/E has moved over time to understand its valuation trends.

Annexon Biosciences in the last 5 years

  • Overview

  • Trends

Lowest (-5.10x)

December 31, 2024

Industry (-7.28x)

December 31, 2025

Today (-3.75x)

December 31, 2025

Highest (-1.99x)

December 31, 2022

LowHigh

Today’s Price to Earnings Ratio: -3.75x

Annexon Biosciences vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Annexon Biosciences with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$866.7M-71.41%-4.530.00%NA
BUY$43.7B669.3%NA0.00%NA
BUY$128.2B154.86%29.8286.04%NA
BUY$25.3B-84.24%-7.98-12.57%NA
BUY$82.7B24.1%19.2484.86%0.44999999999999996%

Stock Returns calculator for Annexon Biosciences Stock including INR - Dollar returns

The Annexon Biosciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Annexon Biosciences investment value today

Current value as on today

₹2,26,165

Returns

₹1,26,165

(+126.17%)

Returns from Annexon Biosciences Stock

₹1,06,967 (+106.97%)

Dollar Impact

₹19,198 (+19.2%)

Analyst Recommendation on Annexon Biosciences Stock

Based on 7 analysts

BUY

71.43%

Buy

14.29%

Hold

14.29%

Sell

Based on 7 analysts, 71.42857142857143% of analysts recommend a 'BUY' rating for Annexon Biosciences. Average target price of $14.71

Annexon Biosciences Share Price Target

Get share price movements and forecasts by analysts on Annexon Biosciences.

What analysts predicted

65.67%UPSIDE

Target Price

$14.71

Current Price

$5.05

Analyzed by

7 Analysts

Target

$14.71

Annexon Biosciences target price $14.71, a slight upside of 65.67% compared to current price of $5.05. According to 7 analysts rating.

Indian Investors' Interest in Annexon Biosciences Stock

Search interest for Annexon Biosciences Stock has increased by 9% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:9% versus previous 30 day period

Annexon Biosciences Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
0
0
-
Operating Income
-28
-33
-39
-52
-57
-51
-57
-50
-46
-57
EBITDA
-24
-28
-34
-48
-53
-48
-54
-47
-43
-54
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-25
-29
-34
-48
-54
-49
-54
-48
-44
-55
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-25
-29
-34
-48
-54
-49
-54
-48
-44
-55
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Annexon Biosciences Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
-
Gross Profit
0
0
-
-
-
-
-
-3
-3
Operating Income
-20
-19
-32
-63
-130
-145
-143
-154
-216
EBITDA
-20
-18
-32
-62
-128
-139
-132
-134
-204
Interest Expense
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
2
2
2
3
2
Income Before Tax
-18
-18
-37
-63
-130
-141
-134
-138
-206
Income Tax Expense
0
0
0
-
-
-
-
-
-
Net Income
-18
-18
-37
-63
-130
-141
-134
-138
-206
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Annexon Biosciences Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-25
-29
-34
-48
-54
-49
-54
-48
-44
-55
Operating Cash Flow
-28
-21
-32
-36
-50
-38
-52
-45
-46
-48
Investing Cash Flow
-77
-96
-45
1
97
73
45
-26
27
39
Financing Cash Flow
32
123
0
4
0
0
13
95
32
32
Change in Cash
-73
5
-77
-30
47
35
7
22
13
24

Annexon Biosciences Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-18
-18
-37
-63
-130
-141
-134
-138
-206
Operating Cash Flow
-19
-17
-28
-53
-106
-116
-121
-118
-186
Investing Cash Flow
0
0
0
-83
-88
58
70
-218
190
Financing Cash Flow
0
58
28
360
1
122
135
161
108
Change in Cash
-19
41
0
224
-193
65
85
-175
112

Mutual Funds that own Annexon Biosciences Stock

Check out the Mutual Funds with significant holdings in Annexon Biosciences.

Funds
Holdings
Shares Held
Fidelity Select Portfolios
4.393056%
7197696
VANGUARD INDEX FUNDS
3.560228%
5833168
TIAA-CREF Funds
1.524765%
2498214
Fidelity Advisor Series VII
1.471839%
2411500
Fidelity Concord Street Trust
1.289383%
2112558

Global Institutional Holdings in Annexon Biosciences

Funds
Holdings
Vanguard
5.22%
iShares
4.71%
SPDR
4.18%
Michael Rockefeller
1.43%
Fidelity
0.63%

Insights on Annexon Biosciences

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, ANNX stock has moved up by 119.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Revolution Medicines, Inc. Common Stock has given 466.0% return, outperforming this stock by 346.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 558.3% return, outperforming this stock by 487.0%

About Annexon Biosciences

Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines for treating inflammatory-related diseases. The company provides Tanruprubart, an investigational full-length monoclonal antibody, which is in Phase 3 clinical trial for the treatment of patients with guillain-barré syndrome; completed Phase II clinical trial for treating Huntington's disease; and in Phase 2a clinical trial for the treatment of amyotrophic lateral sclerosis. It is also developing ANX007, an antigen-binding fragment (Fab) that is in Phase 3 program for the treatment of patients with geographic atrophy; and ANX1502, a novel oral small molecule inhibitor, which is in Phase 1 clinical trials for autoimmune indications. In addition, it develops ANX009, a C1q-blocking Fab that is in Phase I clinical trial for treating patients with lupus nephritis. The company was incorporated in 2011 and is headquartered in Brisbane, California.
OrganisationAnnexon Biosciences
Headquarters1400 Sierra Point Parkway, Brisbane, CA, United States, 94005
IndustryBiotechnology
CEOMr. Douglas E. Love Esq., J.D.
E-voting on sharesClick here to vote

Key Management of Annexon Biosciences

Name

Title

Mr. Shikhar Agarwal M.B.A.

Senior VP & Head of Commercial

Dr. Lloyd Clark M.D.

Senior Vice President of Ophthalmology Strategy & Innovation

Dr. Ted Yednock Ph.D.

Executive VP, Chief Innovation Officer & Chairman of the Scientific Advisory Board

Dr. Dean R. Artis Ph.D.

Chief Scientific Officer & Executive VP

Dr. Jamie Dananberg M.D.

Executive VP & Chief Medical Officer

Mr. Henk-Andre Kroon M.D.

Senior Vice President of Translational Medicine

Dr. Sunil Mehta Pharm.D.

Senior VP of Medical Affairs

Mr. Douglas E. Love Esq., J.D.

CEO, President & Director

Ms. Linda A. Fitzpatrick

Chief Human Resources Officer

Mr. Michael Overdorf M.B.A.

Executive VP & Chief Business Officer

FAQs

What is Annexon Biosciences share price today?

Annexon Biosciences share price today is $5.05 as on at the close of the market. Annexon Biosciences share today touched a day high of $5.13 and a low of $4.80.

What is the 52 week high and 52 week low for Annexon Biosciences share?

Annexon Biosciences share touched a 52 week high of $7.18 on and a 52 week low of $2.03 on . Annexon Biosciences stock price today i.e. is closed at $5.05,which is 29.67% down from its 52 week high and 148.77% up from its 52 week low.

What is Annexon Biosciences's market capitalisation today?

Annexon Biosciences market capitalisation is $0.00T as on .

How to invest in Annexon Biosciences Stock (ANNX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Annexon Biosciences on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Annexon Biosciences Shares that will get you 0.2970 shares as per Annexon Biosciences share price of $5.05 per share as on August 25, 2026 at 1:29 am IST.

What is the minimum amount required to buy Annexon Biosciences Stock (ANNX) from India?

Indian investors can start investing in Annexon Biosciences (ANNX) shares with as little as ₹95.735 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹957.35 in Annexon Biosciences stock (as per the Rupee-Dollar exchange rate as on ). Based on Annexon Biosciences share’s latest price of $5.05 as on August 25, 2026 at 1:29 am IST, you will get 1.9802 shares of Annexon Biosciences. Learn more about fractional shares .

What are the returns that Annexon Biosciences has given to Indian investors in the last 5 years?

Annexon Biosciences stock has given -71.41% share price returns and 29.09% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?